latest news releases from the newsroom
Hemispherx Biopharma, Inc.
Hemispherx Biopharma Reaches Agreement With FDA on Specific Steps to Achieve Complete NDA on Proposed CFS Treatment
PHILADELPHIA, March 6, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced today that, following its submission of a clarifying amendment on January 9, 2008, to its NDA application and a subsequent face-to-face meeting with the Agency, the number of items necessary to accomplish a complete NDA for filing purposes has been reduced from an original fourteen (14) to five (5). Specifically, for NDA filing purposes, 9/14 of the original incomplete items noted in FDA letter received December 5, 2007 are no longer considered filing-related issues. The remaining open items are being promptly addressed by the Company through a series of five (5) additional Amendments to its NDA as described below.
Generex Biotechnology Corp.
Generex Biotechnology to Make Presentations At International Conference On Hypertension, Lipids, Diabetes & Stroke Prevention
WORCESTER, Mass., March 6, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it will be making three poster presentations at the 2nd Annual International Conference on Hypertension, Lipids, Diabetes & Stroke Prevention in Prague, Czech Republic, March 6 - 8, 2008 (www.kenes.com/strokeprevention).
U.S. Mine Makers, Inc.
U.S. Mine Makers, Inc. to Conduct Further Assays and Feasibility Study to Put Idaho Mine Site Into Production
PALM DESERT, Calif., March 6, 2008 (PRIME NEWSWIRE) -- U.S. Mine Makers, Inc. (Pink Sheets:USMM) announced today that CEO Ronald Bell will conduct an inspection of USMM's Idaho mine site, March 11th through the 14th. Mr. Bell will verify all existing claims and entitlements along with the possibility of purchasing new and adjacent claims. Mr. Bell will also conduct a full production feasibility study on a local processing plant, with the intentions of retrofitting the facility to process 200 TPD of ore body, using existing machinery owned by USMM at the site. Additional ore samples will be obtained for assay to estimate the potential value of the properties.
Propalms, Inc. Extends Distribution of TSE Into India
MALTON, England, March 6, 2008 (PRIME NEWSWIRE) -- Propalms, Inc. (Pink Sheets:PRPM) is pleased to announce the Company has extended its sales of TSE products and solutions into India through the signing of a distribution contract with TEQDIS. The agreement will enable Propalms to distribute their TSE software and solutions throughout India.